Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Other hematologic neoplasm 1Lymphoid 1

Conditions

Lymphoma 447Precursor Cell Lymphoblastic Leukemia-Lymphoma 413Lymphoma, Large B-Cell, Diffuse 348Lymphoma, Non-Hodgkin 317Leukemia, Lymphocytic, Chronic, B-Cell 286Leukemia 260Lymphoma, Follicular 241Burkitt Lymphoma 217Lymphoma, Mantle-Cell 202Hodgkin Disease 193Leukemia, Myeloid, Acute 190Myelodysplastic Syndromes 172Lymphoma, B-Cell, Marginal Zone 142Multiple Myeloma 116Lymphoma, Large-Cell, Immunoblastic 116Lymphoma, B-Cell 103Recurrence 100Leukemia, Myelogenous, Chronic, BCR-ABL Positive 76Myeloproliferative Disorders 75Leukemia, Myeloid, Chronic-Phase 73Dendritic Cell Sarcoma, Interdigitating 73Leukemia, Myeloid, Accelerated Phase 72Leukemia, Myelomonocytic, Chronic 67Lymphoma, Large-Cell, Anaplastic 65Waldenstrom Macroglobulinemia 63Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 63Neoplasms, Plasma Cell 59Blast Crisis 58Primary Myelofibrosis 54Congenital Abnormalities 52

Interventions

thymoglobulin 1sargramostim 1ruxolitinib 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Tacrolimus 1Rituximab 1Observation 1Mycophenolic Acid 1Monatide (IMS 3015) 1Methotrexate 1Melphalan 1Granulocyte-Macrophage Colony-Stimulating Factor 1Cyclophosphamide 1Clofarabine 1Busulfan 1Bone Marrow Transplantation 1Blood Specimen Collection 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pathologic Complete Response × Cyclophosphamide × Lymphoid × Clear all
NCT04314219 2025-03-13

PTCy-PMAT

King Faisal Specialist Hospital & Research Center

Phase 3 Recruiting
264 enrolled
LymphoidOther hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡